路透社报道
2026年3月11日 美国东部时间上午10:17 更新于1小时前
节点运行失败
2025年9月24日，在美国宾夕法尼亚州施文克斯维尔拍摄的一剂Moderna Spikevax（新冠病毒疫苗，mRNA）示意图。路透社/汉娜·拜尔 购买授权，新标签页打开
- 公司
- Moderna公司 关注
- 辉瑞公司 关注
3月11日（路透社）- 《华盛顿邮报》周三援引两名知情人士的话报道，美国一个关键的联邦疫苗咨询小组已放弃反对新冠mRNA疫苗的计划。
报道称，在卫生与公众服务部部长小罗伯特·F·肯尼迪（Robert F. Kennedy Jr.）领导下的一些疫苗顾问曾试图可能停止推荐mRNA疫苗，但该计划已不再推进。
订阅路透社健康动态通讯，了解最新的医学突破和医疗趋势。点击此处注册。
负责监管疾病控制与预防中心（CDC）的卫生与公众服务部在常规工作时间外未立即回应路透社的置评请求。
广告 · 继续滚动阅读
CDC顾问定于下周开会，预计将就美国人应何时接种哪些疫苗提出建议。
去年8月，长期活跃的反疫苗活动人士小罗伯特·F·肯尼迪领导的卫生与公众服务部决定终止其生物医学研究部门的mRNA疫苗开发活动。
他曾表示“数据显示这些疫苗未能有效预防新冠和流感等上呼吸道感染”，尽管有相反的科学证据。
这些由辉瑞- BioNTech和Moderna生产的疫苗不含减毒或灭活病毒，而是向细胞发出制造病毒蛋白成分的指令，从而促使人体建立免疫力。
班加罗尔的阿卡姆莎·库什（Akanksha Khushi）报道；安德鲁·海文斯（Andrew Heavens）和安德烈·哈利普（Andrei Khalip）编辑
我们的标准：汤姆森路透信托原则，新标签页打开
- 推荐主题：
- 医疗与制药
- 生物制药
- 公共卫生
US vaccine advisers drop plan to question mRNA COVID shots, WaPo reports
By Reuters
March 11, 2026 10:17 AM UTC Updated 1 hour ago
节点运行失败
An illustration photo shows a dose of Moderna Spikevax (COVID-19 Vaccine, mRNA) taken in Schwenksville, Pennsylvania, U.S. September 24, 2025. REUTERS/Hannah Beier Purchase Licensing Rights, opens new tab
- Companies
- Moderna Inc Follow
- Pfizer Inc Follow
March 11 (Reuters) – A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, the Washington Post reported on Wednesday, citing two people familiar with the matter.
Some vaccine advisers under Health and Human Services Secretary Robert F. Kennedy Jr had been seeking to potentially stop recommending mRNA shots, but that plan is no longer moving forward, the report said.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The Department of Health and Human Services, which oversees the Centers for Disease Control and Prevention, did not immediately respond to a Reuters’ request for comment outside regular working hours.
Advertisement · Scroll to continue
The advisers to the CDC are slated to meet next week and are expected to make recommendations on which vaccines Americans should receive and when.
Under the leadership of Robert F. Kennedy Jr., a longtime anti-vaccine activist, the HHS decided in August last year to wind down mRNA vaccine development activities under its biomedical research unit.
He had said “the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu,” despite scientific evidence to the contrary.
These vaccines, produced by Pfizer-BioNTech and Moderna, do not contain weakened or inactivated viruses, and instead give cells instructions to make a protein component of the virus, prompting the body to build immunity.
Reporting by Akanksha Khushi in Bengaluru; Editing by Andrew Heavens and Andrei Khalip
Our Standards: The Thomson Reuters Trust Principles., opens new tab
- Suggested Topics:
- Healthcare & Pharmaceuticals
- Biopharma
- Public Health
发表回复